Latest

Chart of the Day: Barclays

Chart of the Day: Barclays

1 mins. to read

It is perhaps somewhat difficult to work out why, or how the leading UK banks seem to be on the front foot as far as their price action is concerned, but perhaps the best thing here is not to reason why? Barclays (BARC): 200 Day Line Break Could Lead To 220p It may be said…

Brexit Means…Perplexity – Just Like in Chess

Brexit Means…Perplexity – Just Like in Chess

9 mins. to read

The European politicians who perpetually nudge the United Kingdom to get on with it (that is, to trigger Article 50 and to set out, point-by-point, the definitive post-Brexit blueprint) are like junior chess players who huff and puff because their opponent spends too much time making his first move.  They can’t understand that considered meditation…

A tricky problem

A tricky problem

2 mins. to read

Those who followed me into Solomon Gold, at 3p in March and at 7p two weeks ago, have a short term dilemma. What to do now that the shares have briefly touched 14p and today have bounced off a 10p chart level (but at low volume). Solomon Gold – 10 days to 9th September 2016…

Time to Sell the European Yield Madness

Time to Sell the European Yield Madness

7 mins. to read

At a time when investors need to pay European corporations for the privilege of lending them money, the degree of financial madness should have reached level 100. Governments around the world excused themselves from leading their own sluggish economies towards healthier states and central banks surpassed all known boundaries in replacing them on such a…

The funds trying to do no evil

The funds trying to do no evil

1 mins. to read

It is hard to think of an area that divides opinion more strongly than Socially Responsible Investing (SRI). Those who believe in it think that companies that follow these principles will outperform and by actively engaging with those that don’t they can change the world for the better, whereas sceptics dismiss it as nothing more…

Chart of the Day: GW Pharmaceuticals

Chart of the Day: GW Pharmaceuticals

1 mins. to read

Gaps through the 50 day moving average are normally great momentum indicators. This is especially the case when a stock or market is towards the lower end of the range. In the case of GW Pharma we have a mid-range version of the genre. GW Pharma (GWP): 770p Trendline Target It may be said that…

It’s a Mad, Mad, Mad, Mad World

It’s a Mad, Mad, Mad, Mad World

1 mins. to read

If you want to figure out what’s likely to happen in the next eight months, a good start is to try to understand what’s been happening over the last eight years – since the collapse of Lehman and the beginning of the Global Financial Crisis. Understanding what a portfolio should look like to cope with…

Chart of the Day: Finnaust Mining

Chart of the Day: Finnaust Mining

1 mins. to read

It is usually the case that I prefer to look on the bright side as far as stocks and markets, especially as this tends to be the angle most private investors are most comfortable with. The question is whether with Finnaust Mining this is the best approach at current levels. Finnaust Mining (FAM): Wedge Formation…

India’s Fintech Revolution

India’s Fintech Revolution

1 mins. to read

It was bound to happen – and now it has. India’s love affair with technology and e-commerce has spawned an explosion in “fintech”. We can define fintech as digital technology businesses that compete against (and disrupt) – or sometimes support – the activities of established financial institutions. Businesses in the fintech space serve both customers…